Lifeboat Foundation

First, this study is very biased and flawed. Secondly, have the tech companies considered all of the resistance that we’re all going to face with the provider and payer communities plus their lobbyists when we try to promote medical AI, nanobots, etc.

I have seen some resistance mounted by some providers, some pharma, etc. against CRISPR. And, I believe this type of resistance is only going to hurt patients as well as many cancer survivors with a genetic predisposition to cancer, and other genetic mutations.

A study of mobile health apps’ impact on health care costs represents a limited but crucial step for assessing digital medicine.

Read more

Talk about streamlining and improved efficiencies in clinicals.

Livonia, MI — January 25, 2016 — McKesson Pharmacy Systems & Automation (MPS&A) announced the release of the McKesson Clinical Programs Solution™, a new platform that allows pharmacists to build customized wellness programs and maintain vendor programs for patients with specific medical conditions. The Clinical Programs Solution™ also saves pharmacists time and labor costs by automatically synchronizing the data of patients enrolled in a clinical program with McKesson’s EnterpriseRx® pharmacy management system.

“In today’s increasingly competitive healthcare reimbursement environment, pharmacies are under more pressure than ever to create and manage clinical programs that address patient wellness,” said Emilie Ray, president, McKesson Pharmacy Systems & Automation. “Our Clinical Programs Solution can help meet this challenge by providing pharmacists with a flexible, easy-to-use tool to build and manage clinical services that best suit their patients’ needs and positively impact their pharmacy’s bottom line.”

Read more

With the recent use of genetically engineered mosquitoes in Brazil to halt the spread of the Zika virus, we might be beginning to see some major health improvements as a consequence of the genetics revolution. A world in which mosquitoes were all but eliminated from the ecosystem would look quite different from the world of today, especially for people living in the tropics where the threat of mosquito transmitted infections does more than just mar an otherwise tranquil margarita sipped from the veranda of a beach resort. This is not to beggar the more mundane advantages of a mosquito-free habitat, but rather call attention to the fact that for large parts of the world, including Brazil, mosquitoes can be the difference between life and death.

Ironically, the genetic changes made to the Aedes aegypti mosquito in order to halt the spread of the Zika virus are deceptively simple. The company behind the project, Oxitec, used a modified version of something called the “Sterile Insect Technique” to create their hybrid specimens. The end goal of this process is to produce a male mosquito possessing a “self-limiting gene.” When these males mate with wild female mosquitoes, they create non viable offspring that perish soon after the birth. The end result is a rapid drop in the mosquito population of a given area.

When compared with some of the more hazardous forms of mosquito control currently in use such as massive spraying of DEET and chemical infusers popular throughout Asia, sterilizing mosquitoes sounds like an imminently reasonable approach. As a journalist who once saw his roadside samosa blasted by a massive spray of DEET from an oncoming municipal vehicle in India, I can personally attest to a preference for a genetic solution.

Read more

Could the FDA crush IoT opportunities in Healthcare?

The U.S. Food and Drug Administration last week took a step toward addressing the threat the Internet of Things poses to patients and their data by releasing some proposed guidelines for managing cybersecurity in medical devices.

“A growing number of medical devices are designed to be networked to facilitate patient care. Networked medical devices, like other networked computer systems, incorporate software that may be vulnerable to cybersecurity threats,” the FDA says in its proposal.

Continue reading “FDA Guidelines Target IoT Medical Device Security” »

59% of the providers surveyed recently state that they have no intentions of offering precision treatment such as CRISPR for the next 5 yrs. which means patients with MS, Dystonia, Cancer, etc. will not necessarily get proper choice of treatments that they deserve.

As the Obama administration looks to Congress to fund its $215 million Precision Medicine Initiative, a new poll of healthcare executives indicates that most hospitals and health systems are not planning on leveraging such advances in genomics and data analytics to personalize patient care.

In the poll, conducted by analytics vendor Health Catalyst, 59 percent of respondents indicated that precision medicine will not play a significant role in their organizations over the next five years.

Continue reading “Many healthcare organizations not preparing for precision medicine” »

Healthcare has a new set of hospital cleaners through Maidbot.

Maidbot, an Ithaca-based startup run by Cornell students that combines hospitality and robotics, has gained attention in several competitions around the country, most recently competing against 14 other college startups in the RECESS Pitch Competition earlier this month. “With this new automated system we were really excited to revolutionize and transform the hospitality industry.” —Micah Green ’18.

Additionally, Maidbot was announced as one of 32 semi-finalists in the Student Startup Madness competition — a collegiate startup tournament at SXSW — earlier this month. If Maidbot is to win in the semi-final round, the startup will be able to pitch to investors in Austin, Texas, in March. Inspired by the television show The Jetsons, Maidbot is a robot created to assist hotel room attendants with housekeeping tasks. Micah Green ’18, a co-founder of the company, had previously worked as a room attendant at a hotel.

Read more

When engineers at the University of California, Berkeley, say they are going to make you sweat, it is all in the name of science. Specifically, it is for a flexible sensor system that can measure metabolites and electrolytes in sweat, calibrate the data based upon skin temperature and sync the results in real time to a smartphone.

While health monitors have exploded onto the consumer electronics scene over the past decade, researchers say this device, reported in the Jan. 28 issue of the journal Nature (“Fully integrated wearable sensor arrays for multiplexed in situ perspiration analysis”), is the first fully integrated electronic system that can provide continuous, non-invasive monitoring of multiple biochemicals in sweat.

Continue reading “What new wearable sensors can reveal from perspiration” »

Virtual Healthcare & IMSHealth is a major player in this service offering. Healthcare and clinic in your own home.

The University of Southern California Center for Body Computing has teamed with 8 partners to launch a Virtual Care Clinic. The idea with VCC is to create an integrated approach to the use of mobile apps, “virtual” doctors, artificial intelligence, data collection and analysis, as well as diagnostics and wearable sensors to create truly on-demand healthcare.

The partners involved in this effort are peer-reviewed clinical trial database startup Doctor Evidence, drug data resource IMS Health ($IMS), consumer design firm Karten Design, HIPAA-compliant cloud platform Medable, video creator Planet Grande, sensor-enabled pill startup Proteus Digital Health and vision player VSP Global.

Continue reading “IMS Health, Proteus Digital among 8 founding partners for Keck virtual healthcare clinic” »

Cancer is a mysterious disease for many reasons. Chief among the unknowns are how and why tumors form.

Two University of Iowa studies offer key insights by recording in real time, and in 3-D, the movements of cancerous human breast tissue cells. It’s believed to be the first time cancer cells’ motion and accretion into tumors has been continuously tracked. (See accompanying videos.)

The team discovered that cancerous cells actively recruit healthy cells into tumors by extending a cable of sorts to grab their neighbors—both cancerous and healthy—and reel them in. Moreover, the Iowa researchers report that as little as five percent of cancerous cells are needed to form the tumors, a ratio that heretofore had been unknown.

Read more